B+
Bull case
20%
Probability
Target price
$2.25
+48.0% vs current
SINT
SINTXCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-23
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$1.50
-1.3% vs current
B-
Bear case
30%
Probability
Target price
$0.80
-47.4% vs current
AI sentiment snapshot
Latest data as of 2026-07-14
Recent news sentiment (30D)
+30.0
Positive
Company
-
Unavailable
Macro
+30.0
Positive
Pulse
-
Unavailable
Sentiment proxy
+40.4
Score
AI commentary
The packet shows sparse, low-buzz news flow and no usable analyst revision or target-change evidence. Primary-source evidence supports a real product/commercialization strategy and a balance-sheet transaction, but forward visibility remains weak; sentiment is neutral-to-cautious rather than bullish.
RankAlpha Sentiment Codex - 2026-07-14
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-08-16catalystCapital-structure transaction and resale-registration deadlineHigh impact
The June 29 letter agreement releases 255,267 shares, replaces 251,987 abeyance shares with a pre-funded warrant, and replaces an existing warrant with a 1,268,135-share warrant at $2.14; the company expects improved stockholders’ equity, but dilution and warrant overhang remain material [#8-K-2026-07-02].
2026-12-31eventSINAPTIC foot-and-ankle commercialization proofHigh impact
FDA clearance and initial OsseoSculpt revenue provide a product platform, but the key unresolved milestone is measurable launch, adoption, and recurring revenue rather than additional regulatory validation [#PR-EARNINGS-2025-11-13].
2026-12-31catalystPartnering and adjacent biomaterials expansionHigh impact
Management identified partnering, licensing, KOL engagement, and polymer-composite applications as routes to broaden market access; visibility is limited and no dated agreement is confirmed in the packet [#PR-EARNINGS-2025-11-13].
Recommendation
N/A
No formal recommendation provided.
As of 2026-07-14 • Updated nightlySource: Internal modelMethodology